Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | FPR2 | P25090 | 2/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 1/20 | 0.31 |
| ▸ | HTR1B | P28222 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19985539 | 0.97 | FPR2 (0.32) | SCN9AFPR2ALOX5APFEN1HTR1D | |
| SCHEMBL19985542 | 0.96 | THRA (0.32) | SCN9AFPR2ALOX5APFEN1 | |
| SCHEMBL19985552 | 0.96 | THRA (0.32) | SCN9AFPR2ALOX5APFEN1 | |
| SCHEMBL19985549 | 0.96 | THRA (0.32) | SCN9AFPR2ALOX5APFEN1 | |
| SCHEMBL19985543 | 0.96 | THRA (0.32) | SCN9AFPR2ALOX5APFEN1 | |
| SCHEMBL21614465 | 0.95 | SCN9A (0.36) | SCN9AHTR1DHTR1BGAATDP1 | |
| SCHEMBL8935246 | 0.95 | SCN9A (0.32) | SCN9AFPR2ALOX5APFEN1 | |
| SCHEMBL19985541 | 0.94 | FPR2 (0.36) | FPR2 | |
| SCHEMBL19985214 | 0.92 | SCN9A (0.34) | SCN9AHTR1DHTR1B | |
| SCHEMBL15681288 | 0.92 | SCN9A (0.34) | SCN9AHTR1DHTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079959-A1 | LIQUID CRYSTAL ELEMENT WITH NEGATIVE DIELECTRIC ANISOTROPY | DIC CORPORATION (JP) | 2018-03-22 | — | — | US | disclosed |